Opaleye Management Inc. Mersana Therapeutics, Inc. Transaction History

Opaleye Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$5.65 - $7.86 $2.49 Million - $3.46 Million	-440,300 Reduced 48.91%	460,000 $2.7 Million
Q3 2022 Nov 14, 2022	SELL	$4.63 - $8.0 $679,221 - $1.17 Million	-146,700 Reduced 14.01%	900,300 $6.09 Million
Q2 2022 Aug 15, 2022	BUY	$2.84 - $5.0 $957,080 - $1.69 Million	337,000 Added 47.46%	1,047,000 $4.84 Million
Q1 2022 May 16, 2022	BUY	$3.74 - $6.63 $2.66 Million - $4.71 Million	710,000 New	710,000 $2.83 Million

121

116M

233K

457K

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $216M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.